IB Acquisition Corp. (IBAC) Financial Statements
Industry: Commercial Physical & Biological Research (Services)
In fiscal 2025, IB Acquisition reported revenue of $0. Net income was $3.4M, or $0.22 per diluted share. Operating activities generated -$1.3M of cash. At fiscal year end, IB Acquisition held $17.1M in total assets against $1.8M in total liabilities, including $428,700 of cash and equivalents.
Open the full interactive IB Acquisition financials → Quarterly statements, key ratios, valuation history and price charts.
IB Acquisition Key Stats
| Share Price | $10.86 |
|---|---|
| Market Cap | $46.1M |
| P/E Ratio | 49.4 |
| 52-Week Range | $10.42 – $11.64 |
| Shares Outstanding | 4.2 million (basic, 2026 Q3) |
IB Acquisition Income Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Operating Income | -$523,974 | -$748,908 |
| Pre-Tax Income | $2.5M | $4.4M |
| Income Tax | $635,512 | $965,635 |
| Net Income | $1.9M | $3.4M |
| Diluted EPS | $0.19 | $0.22 |
IB Acquisition Quarterly Results
| 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | $866,365 | -$58,902 | -$639,866 | -$567,166 |
| Diluted EPS | $0.08 | -$0.01 | -$0.11 | -$0.11 |
IB Acquisition Balance Sheet
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash & Equivalents | $822,799 | $428,700 |
| Current Assets | $1.2M | $1.2M |
| Total Assets | $119.8M | $17.1M |
| Current Liabilities | $722,230 | $1.8M |
| Total Liabilities | $722,230 | $1.8M |
| Shareholders' Equity | $1.1M | -$681,323 |
IB Acquisition Cash Flow Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash From Operations | -$820,959 | -$1.3M |
| Cash From Investing | -$115.6M | $107.8M |
| Cash From Financing | $117.2M | -$106.1M |
Figures from IB Acquisition's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full IB Acquisition financials page for every line item.
IB Acquisition Company Profile
| Ticker | IBAC |
|---|---|
| Exchange | Nasdaq |
| Industry | Commercial Physical & Biological Research (Services) |
| Headquarters | Boca Raton, Florida |
| Incorporated in | Nevada |
| Fiscal Year End | September 30 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001998781 |
Frequently Asked Questions
What was IB Acquisition's revenue in fiscal 2025?
IB Acquisition (IBAC) reported revenue of $0 for fiscal 2025.
What was IB Acquisition's net income in fiscal 2025?
IB Acquisition reported net income of $3.4M for fiscal 2025.
What was IB Acquisition's earnings per share (EPS) in fiscal 2025?
IB Acquisition's diluted EPS was $0.22 for fiscal 2025 (adjusted for any later stock splits).
What was IB Acquisition's revenue last quarter?
In its most recent reported quarter (2026 Q3), IB Acquisition reported revenue of $0.
How many shares of IB Acquisition are outstanding?
IB Acquisition reported a weighted average of 4.2 million basic shares outstanding in 2026 Q3.
What is IB Acquisition's market cap?
Based on its latest closing price, IB Acquisition (IBAC) has a market capitalization of about $46.1M.
When does IB Acquisition's fiscal year end?
IB Acquisition's fiscal year end, as registered with the SEC, is September 30.
Where is IB Acquisition headquartered?
IB Acquisition lists its business address in Boca Raton, Florida in its SEC filings.
IB Acquisition Competitors & Similar Companies
See all 12 Commercial Physical & Biological Research (Services) companies →